SMPD3 mutations within human leukemia
Histology . | Nucleotide change . | Amino acid change . | Frequency in controls . |
---|---|---|---|
AML primary | |||
AML1 | c.580G>A | Asp194Asn | 0/166 |
AMLB5 | c.580G>A | Asp194Asn | 0/166 |
AMLB6 | c.580G>A | Asp194Asn | 0/166 |
LEUK139 | c.580G>A | Asp194Asn | 0/166 |
LEUK7 | c.1519G>A | Val507Ile | 0/172 |
ALL primary, ALL. 88-89 | c.580G>A | Asp194Asn | 0/166 |
ALL cell line | |||
KE37 | c.127T>C | Tyr43His | 0/171 |
c.1073A>G | Asp358Gly | 0/176 | |
Mk-B1 | c.284A>T | Tyr95Phe | 0/171 |
c.1073A>G | Asp358Gly | 0/176 | |
c.1495G>C | Glu499Gly | 0/174 | |
JMJURKAT | c.151G>A | Asp51Asn | 0/171 |
c.742G>A | Gly248Ser | 0/166 | |
SUPT1 | c.584G>A | Gly195Glu | 0/166 |
MOLT-4 | c.736C>T | Arg246Cys | 0/166 |
SUPT11 | c.1006C>T | Arg336Cys | 0/166 |
CCRF-CEM | c.1073A>G | Asp358Gly | 0/176 |
Polymorphisms | |||
Ovarian cancer | |||
MDAH2774 | c.1850G>T | Cys617Tyr | 3/43 |
Renal cancer | |||
786-O | c.1850G>T | Cys617Tyr | 3/43 |
Myeloma | |||
RPMI8226 | c.391C>G | Val131Leu | 0/171 |
Histology . | Nucleotide change . | Amino acid change . | Frequency in controls . |
---|---|---|---|
AML primary | |||
AML1 | c.580G>A | Asp194Asn | 0/166 |
AMLB5 | c.580G>A | Asp194Asn | 0/166 |
AMLB6 | c.580G>A | Asp194Asn | 0/166 |
LEUK139 | c.580G>A | Asp194Asn | 0/166 |
LEUK7 | c.1519G>A | Val507Ile | 0/172 |
ALL primary, ALL. 88-89 | c.580G>A | Asp194Asn | 0/166 |
ALL cell line | |||
KE37 | c.127T>C | Tyr43His | 0/171 |
c.1073A>G | Asp358Gly | 0/176 | |
Mk-B1 | c.284A>T | Tyr95Phe | 0/171 |
c.1073A>G | Asp358Gly | 0/176 | |
c.1495G>C | Glu499Gly | 0/174 | |
JMJURKAT | c.151G>A | Asp51Asn | 0/171 |
c.742G>A | Gly248Ser | 0/166 | |
SUPT1 | c.584G>A | Gly195Glu | 0/166 |
MOLT-4 | c.736C>T | Arg246Cys | 0/166 |
SUPT11 | c.1006C>T | Arg336Cys | 0/166 |
CCRF-CEM | c.1073A>G | Asp358Gly | 0/176 |
Polymorphisms | |||
Ovarian cancer | |||
MDAH2774 | c.1850G>T | Cys617Tyr | 3/43 |
Renal cancer | |||
786-O | c.1850G>T | Cys617Tyr | 3/43 |
Myeloma | |||
RPMI8226 | c.391C>G | Val131Leu | 0/171 |